Solo Growth Stock Price, News & Analysis (CVE:ALZ) C$0.06 +0.01 (+9.09%) (As of 01/4/2019) Add Compare Share Share Today's RangeC$0.06▼C$0.0750-Day RangeC$0.06▼C$0.0652-Week RangeC$0.03▼C$0.45Volume3.64 million shsAverage Volume1.68 million shsMarket CapitalizationC$40.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A About Solo Growth Stock (CVE:ALZ)Aldershot Resources Ltd., doing business as Solo Growth Corp., focuses on operating as a retailer for adult-use cannabis in Canada. The company was formerly known as Quattro Resources Ltd. and changed its name to Aldershot Resources Ltd. in July 2001. Aldershot Resources Ltd. was incorporated in 1987 and is headquartered in Calgary, Canada.Read More ALZ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ALZ Stock News HeadlinesNovember 21, 2023 | finance.yahoo.comWall Street Analysts See an 83.21% Upside in Solo Brands, Inc. (DTC): Can the Stock Really Move This High?October 23, 2023 | msn.comSolo Leveling anime reveals new episode update; everything we know so farDecember 6, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comAugust 2, 2023 | newsweek.comAlzheimer'sJuly 26, 2023 | usatoday.comIndigenous researchers work to close gaps in Alzheimer's dataJuly 19, 2023 | uk.style.yahoo.comAlzheimer's disease explained as Fiona Phillips, 62, reveals ‘heartbreaking’ diagnosisJune 15, 2023 | benzinga.comGrowing Opportunities, and Industry Dynamics in Spinal Cord Tumor Market: Major Companies 2023May 6, 2023 | marketwatch.comAlzheimer Disease Treatment Market 2023 to Hit Statistical Significance Value by 2030December 6, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comMay 3, 2023 | finance.yahoo.comGlobal Alzheimer's Therapeutics Market to 2027: Development and Availability of Pipeline Drugs Drives GrowthApril 21, 2023 | msn.comFree/Cheap Ways to Keep Your Brain in Shape as You AgeApril 12, 2023 | msn.comCelebrity Photos From The 2000s That Explain EverythingApril 7, 2023 | msn.comA Woman's Journey of 34 First Dates in 19 Countries: Lessons LearnedApril 6, 2023 | marketwatch.comAlzheimer's Disease Drugs and Diagnostics Market Growth: Demand Forecast Analysis 2023-2029April 3, 2023 | msn.comShe's gone on 34 first dates in 19 countries over the past year. Here's what she's learnedApril 2, 2023 | msn.comShe’s gone on 34 first dates in 19 countries over the past year. Here’s what she’s learnedMarch 29, 2023 | dailymail.co.ukAlzheimer's Disease - Latest news on research, treatment and hopes for cureMarch 28, 2023 | msn.comSundance 2023 Movie Deals So Far: ‘The Pod Generation’ Lands with Roadside and VerticalMarch 23, 2023 | health.usnews.comHomecare for a Loved One With Alzheimer’s or DementiaMarch 19, 2023 | foxnews.comAlzheimer’s diagnoses expected to reach nearly 13 million by 2050, says new reportMarch 18, 2023 | marketwatch.comSolo Microwave Market Analysis: Explosive Growth Opportunity by 2029February 22, 2023 | nypost.comTeenager diagnosed with Alzheimer’s: It can happen at ‘any age’February 21, 2023 | theguardian.comCould Alzheimer’s be caused by an infection?February 19, 2023 | marketwatch.comAlzheimer's Disease Diagnostics and Therapeutics Global Market Report 2023: Increasing Use of Biomarkers for Diagnosis Drives GrowthFebruary 17, 2023 | forbes.comAre You Self-Employed? Check Out a Solo 401(k)February 17, 2023 | reuters.comBiogen CEO bets on Alzheimer's drug, pipeline to return to growthJanuary 26, 2023 | msn.comAlzheimer’s Alliance of Smith County sees growth, in need of volunteersSee More Headlines Receive ALZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solo Growth and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE Industry Industrial Metals & Minerals Sub-IndustryN/A SectorBasic Materials Current SymbolCVE:ALZ CUSIPN/A CIKN/A Webwww.aldershotresources.com Phone403-455-7656FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio13.26 Quick Ratio12.89 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.03 per share Price / Cash Flow1.82 Book ValueC$0.04 per share Price / Book1.50Miscellaneous Outstanding Shares670,065,000Free FloatN/AMarket CapC$40.20 million OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Pali BediCEO, Pres & DirectorMs. Stephanie Ann Bunch (Age 51)CFO & VP of Fin. Mr. Jasbir HansVP of OperationsMr. Theo ZunichVP of Corp. Devel.Mr. Sanjib Singh Gill (Age 42)Corp. Sec. Key CompetitorsTroilus GoldCVE:TLGMax ResourceCVE:MXRCornerstone MetalsCVE:CCCRenaissance Gold Inc. (REN.V)CVE:RENGolden Reign ResourcesCVE:GRRView All Competitors ALZ Stock Analysis - Frequently Asked Questions How have ALZ shares performed in 2023? Solo Growth's stock was trading at C$0.06 at the beginning of the year. Since then, ALZ shares have increased by 0.0% and is now trading at C$0.06. View the best growth stocks for 2023 here. What other stocks do shareholders of Solo Growth own? Based on aggregate information from My MarketBeat watchlists, some companies that other Solo Growth investors own include Oasis Petroleum (OAS), Banco Santander (SAN), Penn Virginia Corporation (PVAHQ) (PVAHQ), Skyworks Solutions (SWKS), Beadell Resources (BDR), Bombardier (BBD), Alacer Gold (ASR), Artemis Resources (ARV), 43844 (AEZ.TO) (AEZ) and Agnico Eagle Mines (AEM). How do I buy shares of Solo Growth? Shares of ALZ stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:ALZ) was last updated on 12/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solo Growth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.